SHOP's global expansion drives strong international growth, with localized payments and cross-border tools boosting merchant adoption and engagement.
Anchor Investment Management LLC boosted its stake in shares of Shopify Inc. (NASDAQ: SHOP) (TSE: SHOP) by 836.0% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 7,582 shares of the software maker's stock after acquiring an additional 6,772 shares
Shopify (SHOP) reported earnings 30 days ago. What's next for the stock?
SHOP is embedding AI across commerce, enabling AI assistants to surface merchant catalogs and route transactions through its checkout and payments infrastructure.
Shopify stock slides over the past six months, but expanding AI commerce capabilities and accelerating global adoption could power future growth.
Shopify (SHOP) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
AI integration, diversified commerce SaaS offerings, and efficient R&D spending reinforce Shopify's competitive moat and sustainable growth trajectory. They leverage AI-powered automation/analytics products like Sidekick and Agentic Commerce to enhance merchant value and maintain their competitive edge. SHOP demonstrate robust growth with FY2025 Rule of 47.3% outperformance and strong FQ1'26 guidance, while also doubling their global commerce SaaS market share compared to 2019 levels.
Shopify is upgraded to a buy as AI integration drives business momentum and positions the company as an agentic commerce leader. Despite gross margin pressure from business mix, Shopify demonstrates strong operating leverage and expense control, with Q4 operating expenses dropping to 29% of revenue. Q4 revenue grew 31% YoY to $3.7B, beating expectations, while Q1 2026 guidance calls for continued revenue growth in the low 30% range.
I am reiterating my “buy” rating on Shopify with a $244 price target, offering 100%+ upside over a 3-year horizon. Despite near-term free cash flow margin contraction, SHOP is positioning itself as the unified operating system of Agentic Commerce, with the launch of UCP, which should expand its surface. Revenue growth remains robust, with Q4 FY25 up 31% YoY, along with strong momentum in its International, Offline and B2B channels as they add new merchants, while existing cohorts strengthen.
Shopify Inc. (SHOP) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript
Sabra Health Care remains a Buy, supported by strong SHOP expansion, robust guidance, and a sustainable 5.84% dividend yield. SBRA projects 4.9%-5.4% FFO growth and plans over $450 million in investments for 2026, with a solid pipeline and a good debt schedule. Leverage is steady at 5x, with recent refinancing extending maturities and reducing interest costs, supporting financial flexibility.